Published in Neural Regen Res on July 01, 2014
Amyloid β peptide-induced inhibition of endothelial nitric oxide production involves oxidative stress-mediated constitutive eNOS/HSP90 interaction and disruption of agonist-mediated Akt activation. J Neuroinflammation (2015) 0.77
Protective effect of bone marrow mesenchymal stem cells on PC12 cells apoptosis mediated by TAG1. Int J Clin Exp Pathol (2015) 0.75
A Genome-Wide Association Study of Attention Function in a Population-Based Sample of Children. PLoS One (2016) 0.75
Notch signaling in cerebrovascular diseases (Review). Mol Med Rep (2016) 0.75
Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem (1971) 28.59
Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun (1984) 20.07
Alzheimer's disease: the amyloid cascade hypothesis. Science (1992) 13.80
The molecular pathology of Alzheimer's disease. Neuron (1991) 8.21
Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci (1993) 7.92
Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature (2000) 4.68
Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci (1997) 4.57
Signaling pathways for PC12 cell differentiation: making the right connections. Science (2002) 3.80
gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in? Nat Rev Neurosci (2002) 2.85
Normal and abnormal biology of the beta-amyloid precursor protein. Annu Rev Neurosci (1994) 2.81
The role of notch in promoting glial and neural stem cell fates. Annu Rev Neurosci (2002) 2.65
Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol Med (2001) 2.63
Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J Neurochem (1995) 2.24
Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. Curr Alzheimer Res (2007) 2.17
The toxicity in vitro of beta-amyloid protein. Biochem J (1995) 2.17
Notch signaling in development and disease. Semin Cancer Biol (2004) 1.97
Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity. Synapse (2000) 1.82
Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death. Proc Natl Acad Sci U S A (1994) 1.79
Involvement of Notch signaling in hippocampal synaptic plasticity. Proc Natl Acad Sci U S A (2004) 1.77
Notch signaling in development and disease. Clin Genet (2003) 1.38
Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol (1998) 1.27
New factors controlling the balance between osteoblastogenesis and adipogenesis. Bone (2011) 1.22
Notch signaling, brain development, and human disease. Pediatr Res (2005) 1.22
Oxidative stress and β-amyloid protein in Alzheimer's disease. Neuromolecular Med (2011) 1.21
Reversible random coil-beta-sheet transition of the Alzheimer beta-amyloid fragment (25-35). Biochemistry (1994) 1.18
Development and mechanism of γ-secretase modulators for Alzheimer's disease. Biochemistry (2013) 1.18
Presenilin, Notch, and the genesis and treatment of Alzheimer's disease. Proc Natl Acad Sci U S A (2001) 1.16
Alzheimer's disease and Notch signaling. Biochem Biophys Res Commun (2009) 1.07
The role of Notch and Rho GTPase signaling in the control of dendritic development. Curr Opin Neurobiol (2001) 1.05
The amyloid hypothesis, time to move on: Amyloid is the downstream result, not cause, of Alzheimer's disease. Alzheimers Dement (2014) 1.02
Deconstructing mitochondrial dysfunction in Alzheimer disease. Oxid Med Cell Longev (2013) 0.99
Soluble γ-secretase modulators selectively inhibit the production of the 42-amino acid amyloid β peptide variant and augment the production of multiple carboxy-truncated amyloid β species. Biochemistry (2014) 0.98
Notch signaling in the brain: in good and bad times. Ageing Res Rev (2013) 0.97
Alzheimer's disease mutations in APP but not γ-secretase modulators affect epsilon-cleavage-dependent AICD production. Nat Commun (2013) 0.97
Postnatal disruption of the disintegrin/metalloproteinase ADAM10 in brain causes epileptic seizures, learning deficits, altered spine morphology, and defective synaptic functions. J Neurosci (2013) 0.97
Neprilysin and Aβ Clearance: Impact of the APP Intracellular Domain in NEP Regulation and Implications in Alzheimer's Disease. Front Aging Neurosci (2013) 0.94
Huperzine A attenuates amyloid beta-peptide fragment 25-35-induced apoptosis in rat cortical neurons via inhibiting reactive oxygen species formation and caspase-3 activation. J Neurosci Res (2002) 0.93
The Alzheimer-related gene presenilin 1 facilitates notch 1 in primary mammalian neurons. Brain Res Mol Brain Res (1999) 0.92
Function and dysfunction of presenilin. Neurodegener Dis (2013) 0.86
Intracellular production of beta A4 amyloid of Alzheimer's disease: modulation by phosphoramidon and lack of coupling to the secretion of the amyloid precursor protein. Biochemistry (1995) 0.83
Protective effect of Bajijiasu against β-amyloid-induced neurotoxicity in PC12 cells. Cell Mol Neurobiol (2013) 0.83
Sulfiredoxin-1 protects PC12 cells against oxidative stress induced by hydrogen peroxide. J Neurosci Res (2013) 0.82
Notch signalling in adult neurons: a potential target for microtubule stabilization. Ther Adv Neurol Disord (2013) 0.82
γ-Secretase inhibitor DAPT attenuates intimal hyperplasia of vein grafts by inhibition of Notch1 signaling. Lab Invest (2014) 0.81
Differential, dominant activation and inhibition of Notch signalling and APP cleavage by truncations of PSEN1 in human disease. Hum Mol Genet (2013) 0.80
GSI promotes vincristine-induced apoptosis by enhancing multi-polar spindle formation. Cell Cycle (2013) 0.79
RNAi-mediated knock-down of Dab and Numb attenuate Aβ levels via γ-secretase mediated APP processing. Transl Neurodegener (2012) 0.79
Protein profiles associated with context fear conditioning and their modulation by memantine. Mol Cell Proteomics (2014) 0.78
[Development of Alzheimer's disease treatment based on the molecular mechanism of γ-secretase activity]. Rinsho Shinkeigaku (2012) 0.78
The γ-secretase inhibitor DAPT increases the levels of gangliosides at neuritic terminals of differentiating PC12 cells. Neurosci Lett (2012) 0.78
An improved cell-based method for determining the γ-secretase enzyme activity against both Notch and APP substrates. J Neurosci Methods (2012) 0.78
Pharmacological characterization of the novel γ-secretase modulator AS2715348, a potential therapy for Alzheimer's disease, in rodents and nonhuman primates. Neuropharmacology (2013) 0.78
Discovery of small molecular (D)-leucinamides as potent, Notch-sparing γ-secretase modulators. Eur J Med Chem (2014) 0.76
Cytotoxic role of advanced glycation end-products in PC12 cells treated with β‑amyloid peptide. Mol Med Rep (2013) 0.76